Release Date: July 31, 2023
Expiration Date: July 31, 2024
Activity Overview
This PER® Spectives™ podcast features a discussion among 3 optometrists on challenges and unmet needs associated with traditional treatments for meibomian gland dysfunction (MGD)-related dry eye disease (DED) — and opportunities for MGD treatment that may come with new and emerging topical therapies. In addition, the panel discusses myths and misconceptions that may affect outcomes in patients with MGD-DED. This program is designed to help clinicians better appreciate the impact of MGD-DED on patients and optimize the growing toolkit of available therapies.
Target Audience
This educational activity will be targeted to practitioners who are involved in treating patients with MGD, such as optometrists, ophthalmologists, NPs, PAs, and nurses.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Analyze key trial data and real-world evidence surrounding current treatments for MGD-associated DED
- Evaluate key clinical trial data for emerging agents being studied for the potential treatment of MGD-associated DED
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
